MULLENNIX STEPHEN (COO) sold 7.3% of their position (684.00 shares) of UROGEN PHARMA LTD. on the open market
Open‑market sale worth $20.0K — a moderate reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 1/28/2020ACC: 0001209191-20-005211
-684.00
Net shares
Net seller
$20.0K
Total sold
1
Open market trades
0B · 1S
3
Total transactions
1.67K acquired · 2.35K disposed
Non-Derivative Transactions2
Ordinary Shares
Direct
Shares
+1.67K
Price / share
—
Trade value
—
% of position
21.7%
1/26/2020
7.68K→9.35K
Ordinary Shares
Direct
Shares
−684.00
Price / share
$29.26
Trade value
$20.01K
% of position
7.3%
1/27/2020
9.35K→8.66K
Total
Net shares
+982.00
Net value
-$20.01K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Ordinary Shares Direct | 1/26/2020 | M · Option Exercise | +1.67K | — | — | 21.7% | 7.68K | 9.35K |
| Ordinary Shares Direct | 1/27/2020 | S · Sale | −684.00 | $29.26 | $20.01K | 7.3% | 9.35K | 8.66K |
| Total | +982.00 | -$20.01K | ||||||
Derivative Transactions1
Restricted Stock Units (RSUs)
Direct
Converts to
Ordinary Shares
1.67K shares
Shares
−1.67K
Strike price
Held after
3.33K
Exercisable
—
1/26/2020
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Restricted Stock Units (RSUs) Direct | Ordinary Shares1.67K shares | 1/26/2020 | M · Option Exercise | −1.67K | — | 3.33K |